WALTHAM, Mass. – Oct. 25, 2016 – Fresenius Medical Care North America, the leading provider of kidney care products and services across the continent, announced today that its dialysis services business, Fresenius Kidney Care, achieved the country’s largest number of top-rated Five-Star dialysis centers, based on the annual Dialysis Facility Compare Five-Star Quality Rating System issued by the Centers for Medicare and Medicaid Services (CMS).

Based on quality measures gathered within U.S. dialysis centers during the 2015 treatment year, the latest federal government rating shows Fresenius Kidney Care operates the most four- and five-star centers among all major dialysis providers, both in terms of absolute number of clinics and percentage of clinics owned.

“High-quality care is not possible without high-quality people, and I am humbled to work with such a remarkable group of caring individuals who are the life force behind everything we do,” said Bill Valle, President of Fresenius Kidney Care. “Each of our employees, physician partners, and medical directors values our patients as family, and we strive to do all we can to help our patients live longer, thriving lives, caring for them the way we would want our own family cared for.”

Fresenius Kidney Care’s latest Five-Star rating builds on a track record of success. Each year since 2006, the company has helped patients live longer and spend less time in the hospital, improving mortality rates of its dialysis patients and lowering the average time spent in a hospital setting by two-and-a-half days.

Fresenius Medical Care North America is the largest vertically integrated dialysis provider in North America, as well as the largest participant in CMS’s Comprehensive End-Stage Renal Disease (ESRD) Care Initiative, the nation’s first disease-specific shared savings program, designed to identify, test, and evaluate new ways to improve care for ESRD patients. As a trailblazer in this initiative, Fresenius Medical Care North America operates six ESRD Seamless Care Organizations (ESCOs) across the country—more than any other provider—innovating beyond traditional methods of care delivery with a patient-centric focus that addresses the unique needs of each individual, both in and outside the dialysis center.

“As the leader in kidney care innovation, our mission is to improve the quality of life for every patient, every day, and that means imagining new models of personalized medicine beyond what current policy envisions,” said Dr. Franklin Maddux, Fresenius Medical Care North America’s Chief Medical Officer and Executive Vice President of Clinical and Scientific Affairs. “Our Five-Star performance reflects the dedication and clinical excellence of every one of our caregivers, nurses, physician partners, and clinical innovators. We are proud of these results and will strive to continually improve.”

About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis centers, outpatient cardiac and vascular labs, and urgent care centers, as well as the continent’s largest practice of hospitalist and post-acute providers, Fresenius Medical Care North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers. As the world’s largest fully vertically integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit www.FMCNA.com.

About Fresenius Kidney Care
Fresenius Kidney Care, a division of Fresenius Medical Care North America (FMCNA), provides dialysis treatment and services to nearly 200,000 people with kidney disease at more than 2,200 dialysis centers nationwide. Fresenius Kidney Care supports people by helping to address both the physical and emotional aspects of kidney disease through personalized care, education, and lifestyle support services so they can lead meaningful and fulfilling lives. Fresenius Kidney Care patients have access to Fresenius Medical Care North America’s integrated network of kidney care services, as highlighted above. As a leader in renal care technology, innovation, and clinical research, FMCNA’s more than 67,000 employees are dedicated to the mission of delivering superior care that improves the quality of life for people with kidney disease. For more information, visit www.FreseniusKidneyCare.com and like us on Facebook.

Media Contact:
Jon Stone
Jonathan.d.stone@fmc-na.com
Office: 781-699-9704
Cell: 781-392-4680